Apellis Pharmaceuticals Inc ROIC
Mi az Apellis Pharmaceuticals Inc ROIC?
A ROIC az Apellis Pharmaceuticals Inc - -64.16%
Mi a ROIC meghatározása?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC a Health Care szektor a NASDAQ-on cégekben a Apellis Pharmaceuticals Inc -hoz képest
Mit csinál Apellis Pharmaceuticals Inc?
apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.
roic -hoz hasonló cégek Apellis Pharmaceuticals Inc
- Gritstone Bio Inc nak ROIC -64.25% van
- POET Technologies nak ROIC -64.23% van
- Interconnect Ventures nak ROIC -64.21% van
- Marathon Patent nak ROIC -64.18% van
- Skeena Resources nak ROIC -64.18% van
- Transphorm nak ROIC -64.17% van
- Apellis Pharmaceuticals Inc nak ROIC -64.16% van
- Professional Diversity Network nak ROIC -64.13% van
- Atomo Diagnostics nak ROIC -64.10% van
- GeneNews nak ROIC -64.08% van
- Dragon Victory International Ltd nak ROIC -64.05% van
- OzAurum Resources nak ROIC -64.03% van
- STARAMBA SE nak ROIC -64.01% van